MF-094 NEW
| Price | $36 | $89 | $147 |
| Package | 1mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-27 |
Product Details
| Product Name: MF-094 | CAS No.: 2241025-68-1 |
| Purity: 99.93% | Supply Ability: 10g |
| Release date: 2026/07/27 |
Product Introduction
Bioactivity
| Name | MF-094 |
| Description | MF-094 is a selective USP30 inhibitor with IC50 of 0.12 μM. MF-094 can increase protein ubiquitination and accelerate mitophagy. |
| In vitro | In hypoxic trophoblast cells supplemented with MF-094, GSH and SOD levels increased, while MDA levels decreased. [2] |
| In vivo | Subcutaneous injection of MF-094 can promote the ubiquitination level of FUNDC1. MF-094 can significantly reduce the increase in systolic blood pressure and urine protein in PE mice. [2] |
| Storage | Store at low temperature,Keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : < 10 mg/mL (18.67 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. 10% DMSO+90% Saline : < 10 mg/mL (18.67 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. DMSO : 150 mg/mL (280.01 mM), Sonication is recommended. 10% DMSO+90% (20% SBE-β-CD in Saline) : < 10 mg/mL (18.67 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. 10% DMSO+90% Corn oil : 10 mg/mL (18.67 mM), Solution. |
| Keywords | USP30 | MF-094 | MF094 | MF 094 | Inhibitor | inhibit | DUBs | Deubiquitinase |
| Inhibitors Related | P22074 | USP7-IN-4 | N-Ethylmaleimide | DUB-IN-1 | SJB3-019A | USP30 inhibitor 11 | Vialinin A | GRL0617 | Spautin-1 | USP8-IN-3 | 6-Thioguanine | IU1 |
| Related Compound Libraries | Mitochondrial Membrane Protein-Targeted Compound Library | Bioactive Compound Library | Ubiquitination Compound Library | Bioactive Compound Library Plus | Inhibitor Library | Mitochondria-Targeted Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $36.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-07-15 | |
| $2800.00 |
VIP3Y
|
TargetMol Chemicals Inc.
|
2026-07-15 | |
| $1.00 |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-18 | ||
| $36.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-07-14 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY